• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

InVivo Therapeutics

Invivo Therapeutics raises $3m

April 29, 2020 By Sean Whooley

InVivo Therapeutics (NSDQ:NVIV) filed an SEC Form D to confirm the sale of more than $3 million in options, warrants and/or other rights to acquire other securities. The Cambridge, Mass.-based spinal cord injury treatment developer sold its entire offering amount of $3,022,576. It included a private placement of warrants to purchase more than 1.7 million shares […]

Filed Under: Business/Financial News, Funding Roundup, Orthopedics, Spine Tagged With: InVivo Therapeutics

InVivo Therapeutics prices $7m offering

March 9, 2020 By Sean Whooley

InVivo Therapeutics (NSDQ:NVIV) announced last week that it priced a public offering of common stock shares and warrants totaling approximately $7 million. The offering is set to include more than 2.5 million shares of common stock or pre-funded warrants to purchase common stock, along with standard warrants to purchase up to more than 2.5 million shares […]

Filed Under: Business/Financial News, Funding Roundup, Orthopedics, Spine, Wall Street Beat Tagged With: InVivo Therapeutics

InVivo Therapeutics stock down after reverse stock split

February 12, 2020 By Sean Whooley

InVivo Therapeutics’ (NSDQ:NVIV) recently announced 1-for-30 reverse stock split went into effect last night, and shares have taken a hit today as a result. NVIV was down -10.2% at $6.95 per share in midday trading today. Cambridge, Mass.–based spinal cord injury treatment developer initially announced the common stock split earlier this month, sharing that every 30 […]

Filed Under: Business/Financial News, Featured, Neurological, Spine, Wall Street Beat Tagged With: InVivo Therapeutics

InVivo prices $1m public stock offering

November 22, 2019 By Sean Whooley

InVivo Therapeutics (NSDQ:NVIV) announced that it priced a public stock offering expected to produce gross proceeds of just under $1 million for the company. The Cambridge, Mass.-based company is offering 7 million shares of its common stock to the public at a price of 12¢ per share. InVivo expects the gross proceeds to reach $840,000, before […]

Filed Under: Funding Roundup, Neurological, Spine Tagged With: InVivo Therapeutics

Pixarbio CEO Reynolds convicted in $13m investor fraud case

October 29, 2019 By Brad Perriello

Pixarbio founder & CEO Frank Reynolds reportedly faces two decades behind bars after a jury yesterday convicted him of defrauding investors of nearly $13 million. Federal authorities arrested Reynolds, longtime friend and Pixarbio employee Jay Herod and PixarBio CIO Kenneth Stromsland in April 2018 on securities fraud charges, claiming they misled investors about the opioid substitute […]

Filed Under: Featured, Legal News, Pharmaceutical, Wall Street Beat Tagged With: InVivo Therapeutics, PixarBio

InVivo Therapeutics launches new neuro-spinal scaffold study

May 29, 2019 By Fink Densford

InVivo Therapeutics (NSDQ:NVIV) said today that it launched a new trial of its neuro-spinal scaffold, dubbed the INSPIRE 2.0 study, and that it has enrolled the first two patients into the study. The Cambridge, Mass.-based company won FDA approval to launch the new pivotal study of the device last March, after ending the previous Inspire study of the […]

Filed Under: Clinical Trials, Neurological, Spine Tagged With: InVivo Therapeutics

InVivo Therapeutics releases 12-month Inspire study results

April 18, 2019 By Fink Densford

InVivo Therapeutics (NSDQ:NVIV) yesterday presented twelve-month results from the single-arm INSPIRE study of its neuro-spinal scaffold. The Cambridge, Mass.-based company’s neuro-spinal scaffold is a novel, biodegradable device designed to be surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. Results from the trial were presented at the 2019 AANS Meeting in […]

Filed Under: Clinical Trials, Neurological, Spine Tagged With: InVivo Therapeutics

JenaValve names Kilcoyne as CEO | Personnel Moves – January 15, 2019

January 15, 2019 By Fink Densford

JenaValve Technology said today that it named former ReVision Optics prez & CEO John Kilcoyne as its new chief executive officer, effective immediately, replacing Dr. Victoria Carr-Brendell, who has taken up an executive leadership position with Sonova Holding AG (SIX:SOON). Prior to his time at ReVision Optics, Kilcoyne served as prez & CEO at Micrus Endovascular where he […]

Filed Under: Business/Financial News, Featured Tagged With: apyxmedical, biogennix, Cardiac Dimensions, Cardiovascular Systems Inc., Coorstek, Covidien, DaVita Inc., Digirad Corp., Endologix, ev3 Inc., Integra LifeSciences, Intuitive Surgical, InVivo Therapeutics, JenaValve, Johnson and Johnson, Medtronic, mentice, Micrus Endovascular Corp., Natus Medical Inc., Outset Medical, Patterson Companies, ReVision Optics Inc., Solace Therapeutics, Sonova Holding AG, Xtant Medical

InVivo inks joint research deal with cell therapy dev Q Therapeutics

October 2, 2018 By Fink Densford

InVivo Therapeutics (NSDQ:NVIV) said today it inked a joint research agreement with clinical-stage central nervous system cell therapy developer Q Therapeutics. Through the deal, InVivo is looking to combine its neuro-spinal scaffold technology with Q Therapeutics’ adult neural progenitor cells, Cambridge, Mass.-based InVivo said. Both companies will share their technologies and explore the potential combination’s safety […]

Filed Under: Business/Financial News, Neurological, Research & Development, Spine Tagged With: InVivo Therapeutics, qtherapeutics

InVivo touts 1-year Inspire study results

August 28, 2018 By Fink Densford

InVivo Therapeutics (NSDQ:NVIV) today released 12-month results from the closed Inspire study of its neuro-spinal scaffold, touting improvements in ASIA impairment scales. The Cambridge, Mass.-based company’s neuro-spinal scaffold is a novel, biodegradable device designed to be surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. Of the 16 patients in […]

Filed Under: Clinical Trials, Spine Tagged With: InVivo Therapeutics

InVivo Therapeutics shares down as losses grow in Q2 earnings release

August 8, 2018 By Fink Densford

Shares in InVivo Therapeutics (NSDQ:NVIV) fell today after the medical device maker missed expectations on Wall Street with its second quarter results. The Cambridge, Mass-based company posted losses of $12.9 million, or $7.48 per share, up 104.1% as compared with the same period during the previous year. Losses per share were well behind the 41¢ expectations […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: InVivo Therapeutics

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 17
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS